Evaluation of quality of life in patients with onychomycosis using the Polish version of Dermatology Life Quality Index;Ocena jakości życia pacjentów z grzybica̧ paznokci z wykorzystaniem polskiej wersji kwestionariusza Dermatology Life Quality Index

Mikologia Lekarska

Volumn 13, Issue 3, 2006, Pages 193-198

  Szepietowski, Jacek ^a   Reich, Adam ^a   Woźniak, Michał ^b   Baran, Eugeniusz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Grodziskie Zakłady Farmaceutyczne Polfa Sp z oo ^*

Author keywords

DLQI; Onychomycosis; Quality of life

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DERMATOMYCOSIS; FEMALE; FINGERNAIL ONYCHOMYCOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; POLAND; QUALITY OF LIFE; QUALITY OF LIFE INDEX; TOENAIL ONYCHOMYCOSIS;

EID: 33749479212     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Baran R., Dawber R.P.R.: Diseases of the nails and their management. Blackwell Science, Oxford, 1994.
2. Sikora M., Pachołek T., Soter K., Szepietowski J.: Analysis of fungal skin and skin appendages infections In the region of Wrocław in the years 1995-1999. Mikol. Lek., 2000, 7, 145-151.
3. Roberts D.T.: Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br. J. Dermatol., 1992, 126, 23-37.
4. Heikkala H., Stubbs S.: The prevalence of onychomycosis in Finland. Br. J. Dermatol., 1995, 133, 699-701.
5. Gupta A.K., Jain H.C., Lynde C.W., Watteel G.N., Summerbell R.C.: Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada - a multicenter survey of 2001 patients. Int. J. Dermatol., 1997, 36, 783-787.
6. Roberts D.T.: Onychomycosis: current treatment and future challenges. Br. J. Dermatol., 1999, 141, Supl. 56, 1-4.
7. Szepietowski J.C.: Selected clinical aspects of onychomycosis. Mikol. Lek., 2004, 11, 119-128.
8. Scher R.K.: Onychomycosis is more than a cosmetic problem. Br. J. Dermatol., 1994, 130, Suppl. 43, 15.
9. Lubeck D.P., Patrick D.L., McNulty P., Fifer S.K., Birnbaum J.: Quality of life of persons with onychomycosis. Qual. Life Res., 1993, 2, 341-348.
10. Elewski B.E.: The effect of toenail onychomycosis on patient quality of life. Int. J. Dermatol., 1997, 36, 754-756.
11. Whittam L.R., Hay R.J.: The impact of onychomycosis on quality of life. Clin. Exp. Dermatol., 1997, 22, 87-89.
12. Drake L.A., Scher R.K., Smith E.B., Faich G.A., Smith S.L., Hong J.J., Stiller M.J.: Effect of onychomycosis on quality of life. J. Am. Acad. Dermatol., 1998, 38, 702-704.
13. Drake L.A., Patrick D.L., Fleckman P., Andre J., Baran R., Haneke E., Sapede C., Tosti A.: The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life. J. Am. Acad. Dermatol., 1999, 41, 189-196.
14. Lubeck D.P., Gause D., Schein J.R., Prebil L.E., Potter L.P.: A health-related quality of life measure for use in patients with onychomycosis: a validation study. Qual. Life Res., 1999, 8, 121-129.
15. Millikan L.E., Powell D.W., Drake L.A.: Quality of life for patients with onychomycosis. Int. J. Dermatol., 1999, 38, Supl. 2, 13-16.
16. Turner R.R., Testa M.A.: Measuring the impact of onychomycosis on patient quality of life. Qual. Life Res., 2000, 9, 39-53.
17. Shaw J.W., Joish V.N., Coons S.J.: Onychomycosis: health-related quality of life considerations. Pharmacoeconomics, 2002, 20, 23-36.
18. Szepietowski J., Salomon J., Finlay A.Y., Klepacki A., Chodynicka B., Marionneau N., Charles T., Myon E.: Wskaźnik wpływu dolegliwości skórnych na jakość życia - Dermatology Life Quality Index (DLQI): polska wersja jȩzykowa. Dermatol. Klin., 2004, 6, 63-70.
19. Hongbo Y., Harrison M.A., Salek M.S., Finlay A.Y.: Translating the science of quality of life into practice: What the Dermatology Life Quality Index scores mean? J. Invest. Dermatol., 2005, 125, 659-664.
20. Kowalczuk-Zieleniec E., Nowicki E., Majkowicz M.: Onychomycosis changes quality of life. J. Eur. Acad. Dermatol. Venerol., 2002, 16, Supl. 1, 248 (P23-20).
21. Firooz A., Khamesipour A., Dowlati Y.: Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. J. Dermatol. Treat. 2003, 14, 95-98.